2,770 results on '"BALZARINI, J."'
Search Results
202. ChemInform Abstract: Synthesis and Biological Evaluation of 1,2-Disubstituted Carbonucleosides of 2-Amino-6-substituted Purine and 8-Azapurine.
203. ChemInform Abstract: 4-(β-Arylvinyl)-3-(β-arylvinylketo)-1-ethyl-4-piperidinols and Related Compounds: A Novel Class of Cytotoxic and Anticancer Agents.
204. ChemInform Abstract: Stereospecific Synthesis and Antiviral Activities of β-L-2′,3′-Dideoxy-5-chloropyrimidine Nucleoside Derivatives
205. ChemInform Abstract: Synthesis and Biological Evaluation of 1,2-Disubstituted Carbonucleosides of 6-Substituted Purine and 8-Azapurine
206. ChemInform Abstract: Synthesis and Evaluation of Antiviral Activity of Higher Homologues of Xylo-carbocyclic Nucleosides
207. ChemInform Abstract: Acyclic/Carbocyclic Guanosine Analogues as Anti-Herpesvirus Agents
208. ChemInform Abstract: “Second Generation” of TSAO Compounds Directed Against HIV-1 TSAO-Resistant Strains
209. ChemInform Abstract: Synthesis and Biological Activities of (Z) and (E) α-Ethenyl Acyclonucleosides.
210. Human immunodeficiency virus type 1 drug-resistance patterns with different 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives
211. Synthesis and anti-HIV activity of 4'-C-ethynyl-2'-deoxy-4'-thio-nucleosides
212. Structural basis for the specificity of thymidylate kinases from human pathogens: implications for nucleotide analogues activation
213. FV100 as a new approach for the possible treatment of varicella-zoster virus infection
214. Crystal structure of vaccinia virus thymidylate kinase bound to TDP
215. Crystal structure of vaccinia virus thymidylate kinase bound to brivudin-5'-monophosphate
216. Thymidine analogs as potential antiviral agents
217. Nucleoside Diphosphate Prodrugs
218. Design and development of curcumin bioconjugates as antiviral agents
219. [18F]FDG and [18F]FLT uptake in human breast cancer cells in relation to the effects of chemotherapy: an in vitro study
220. Reduced Levels of Mitochondrial DNA Increases the Toxicity of 9-ß-D-Arabinofuranosylguanine (araG)
221. Design and Synthesis of Novel Non-nucleoside Anti-HCMV Agents
222. Diffusion of Two Potential Anti-HIV Microbicides across Intact and De-Epithelialised, Human Vaginal Mucosa
223. Carbohydrate-binding agents (CBAs) inhibit HIV-1 infection in human primary monocyte-derived macrophages (MDMs) and efficiently prevent MDM-directed viral capture and subsequent transmission to CD4+ T lymphocytes
224. Synthesis and biological evaluation of 2-(2-deoxy-β-D-ribofuranosyl)pyridine-4-carboxamide
225. Synthesis and Biophysical Characterization of G-Rich Oligonucleotides Conjugated with Sugar-Phosphate Tails
226. NewCycloAMB-Nucleoside Phosphonate Prodrugs
227. 5-Diacetoxymethyl-cycloSal-d4TMP—A prototype of enzymatically activatedcycloSal-pronucleotides
228. Preclinical development of bicyclic nucleoside analogues as potent and selective inhibitors of varicella zoster virus
229. Antiviral activity of carbohydrate-binding agents against Nidovirales in cell culture
230. In Vivo Antiviral Activity of 1-(S)-[3-Hydroxy-2-(Phosphonomethoxy)Propyl]-5-Azacytosine and its Cyclic Form
231. Chemical Stability and Intracellular Metabolism of 1-(S)-[3-Hydroxy-2-(Phosphonomethoxy)Propyl]-5-Azacytosine
232. Design, Synthesis, and Biological Evaluation of Novel Anti-VZV Agents
233. The Design, Synthesis and Anti-HIV Activity of a Selected Group of 2′,3′-Didehydro-2′,3′-Dideoxyguanosine (d4G) and 2′,3′-Dideoxyguanosine (ddG) ‘ProTide’ Derivatives
234. Carbohydrate-Binding Agents (CBAs) Potently Inhibit HIV Infection In Human Primary Monocytes/Macrophages and Efficiently Prevent Viral Capture and Subsequent Transmission to CD+4 T Lymphocytes
235. Synthesis and Antiviral Activity of 1-(S)-[3-Hydroxy-2-(Phosphonomethoxy)Propyl]-5-Azacytosine and its Ester Prodrugs
236. Design and Synthesis of Novel Anti-HCMV Agents: Modifications to the Bicyclic Pyrimidine Base
237. Properties of Aminoacid Esters Linked to Cyclo Sal-Pronucleotides
238. Synthesis and biological evaluation of some D-xylofuranosyl-pyridine-C-nucleosides
239. Structure of vaccinia virus thymidine kinase in complex with dTTP: insights for drug design
240. Pronounced in vitro and in vivo antiretroviral activity of 5-substituted 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy] pyrimidines
241. Structural basis for non-competitive product inhibition in human thymidine phosphorylase: implication for drug design
242. Enhanced toxicity of purine nucleoside analogs in cells expressing Drosophila melanogaster nucleoside kinase mutants
243. Thymidine Phosphorylase is Noncompetitively Inhibited by 5′-O-Trityl-Inosine (KIN59) and Related Compounds
244. Study of the Efficacy of a Pronucleotide of 2-Chloro-2′-Deoxyadenosine in Deoxycytidine Kinase-Deficient Lymphoma Cells
245. Alterations of Mitochondrial DNA in CEM Cells Selected for Resistance Toward DDC Toxicity
246. Substrate Specificity of Three Viral Thymidine Kinases (TK): Vaccinia Virus TK, Feline Herpesvirus TK, and Canine Herpesvirus TK
247. THE JOURNEY TOWARDS ELUCIDATING THE ANTI-HCMV ACTIVITY OF ALKYLATED BICYCLIC FURANO PYRIMIDINES
248. ANTIVIRAL POTENTIAL OF A NEW GENERATION OF ACYCLIC NUCLEOSIDE PHOSPHONATES, THE 6-[2-(PHOSPHONOMETHOXY)ALKOXY]-2,4-DIAMINOPYRIMIDINES
249. NOVEL CYCLOSAL NUCLEOTIDES WITH REDUCED INHIBITORY POTENCY TOWARD HUMAN BUTYRYLCHOLINESTERASE
250. SYNTHESIS AND BIOLOGICAL EVALUATION OF N- AND O-ALKYLATED BICYCLIC FURANOPYRIMIDINES AS NON-NUCLEOSIDIC INHIBITORS OF HUMAN CYTOMEGALOVIRUS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.